MJN110
CAS: 1438416-21-7
Ref. 3D-NHC41621
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Product Information
MJN110 is a novel drug that inhibits the activity of fatty acid amide hydrolase (FAAH), an enzyme that breaks down anandamide, one of the body's natural endocannabinoids. MJN110 has been shown to have potent antinociceptive and anti-inflammatory effects in animal models. It also has been shown to have beneficial effects on chronic viral hepatitis, as well as other diseases such as type 2 diabetes, neuropathic pain, and Parkinson's disease. MJN110 may be used as an analgesic, anti-inflammatory agent, or agent for treating chronic viral hepatitis.
Chemical properties
Technical inquiry about: 3D-NHC41621 MJN110
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
